Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19.
作者信息
Spinoni Enrico Guido, Mennuni Marco, Rognoni Andrea, Grisafi Leonardo, Colombo Crizia, Lio Veronica, Renda Giulia, Foglietta Melissa, Petrilli Ivan, D'Ardes Damiano, Sainaghi Pier Paolo, Aimaretti Gianluca, Bellan Mattia, Castello Luigi, Avanzi Gian Carlo, Corte Francesco Della, Krengli Marco, Pirisi Mario, Malerba Mario, Capponi Andrea, Gallina Sabina, Pierdomenico Sante Donato, Cipollone Francesco, Patti Giuseppe
机构信息
Università del Piemonte Orientale, Novara (E.G.S., L.G., C.C., V.L., P.P.S., G.A., M.B., L.C., G.C.A., F.D.C., M.K., M.P., M. Malerba, G.P.).
Maggiore della Carità Hospital, Novara (E.G.S., M. Mennuni, A.R., L.G., C.C., V.L., P.P.S., G.A., M.B., L.C., G.C.A., F.D.C., M.K., M.P., A.C., G.P.).
出版信息
Circ Arrhythm Electrophysiol. 2021 Feb;14(2):e009375. doi: 10.1161/CIRCEP.120.009375. Epub 2021 Feb 16.
Abstract
摘要
相似文献
1
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19.
Circ Arrhythm Electrophysiol. 2021 Feb;14(2):e009375. doi: 10.1161/CIRCEP.120.009375. Epub 2021 Feb 16.
2
Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19.
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3077-3085. doi: 10.1111/jce.14770. Epub 2020 Oct 14.
3
QTc Interval and Mortality in a Population of SARS-2-CoV Infected Patients.
Circ Arrhythm Electrophysiol. 2020 Nov;13(11):e008890. doi: 10.1161/CIRCEP.120.008890. Epub 2020 Sep 29.
4
Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection.
Heart Rhythm. 2021 Apr;18(4):501-507. doi: 10.1016/j.hrthm.2021.01.018. Epub 2021 Jan 22.
5
Clinical Impact of Atrial Fibrillation on Short-Term Outcomes and In-Hospital Mortality in Patients with Takotsubo Syndrome: A Propensity-Matched National Study.
Cardiovasc Revasc Med. 2020 Apr;21(4):522-526. doi: 10.1016/j.carrev.2019.07.022. Epub 2019 Jul 23.
6
Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort.
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3086-3096. doi: 10.1111/jce.14772. Epub 2020 Oct 20.
7
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection.
Open Heart. 2020 Nov;7(2). doi: 10.1136/openhrt-2020-001428.
8
Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome.
J Am Heart Assoc. 2020 Nov 17;9(22):e017364. doi: 10.1161/JAHA.120.017364. Epub 2020 Oct 7.
9
Registry Study Describes COVID-19 Mortality and Hospitalization in Patients with Breast Cancer.
Oncologist. 2021 Feb;26 Suppl 2(Suppl 2):S17-S18. doi: 10.1002/onco.13664. Epub 2021 Jan 5.
10
Association of Follow-Up Care With Long-Term Death and Subsequent Hospitalization in Patients With Atrial Fibrillation Who Receive Emergency Care in the Province of Ontario.
Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e006498. doi: 10.1161/CIRCEP.118.006498. Epub 2019 Dec 16.
引用本文的文献
1
Individuals Recovered from Severe COVID-19 are Predispose to Develop Atrial Fibrillation.
Int J Gen Med. 2025 Aug 12;18:4379-4390. doi: 10.2147/IJGM.S527058. eCollection 2025.
2
Demographic trends in mortality with older population due to atrial fibrillation and flutter from 1999-2020.
World J Cardiol. 2025 Jan 26;17(1):99933. doi: 10.4330/wjc.v17.i1.99933.
3
Clinical Characteristics and Outcomes in Patients with Chronic HBV Infection and Hospitalized for COVID-19 Pneumonia: A Retrospective Cohort Study.
Viruses. 2024 Dec 30;17(1):40. doi: 10.3390/v17010040.
4
A pooled analysis of the incidence and mortality risk of atrial fibrillation in patients with COVID-19.
PeerJ. 2024 Oct 16;12:e18330. doi: 10.7717/peerj.18330. eCollection 2024.
5
SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugs.
Europace. 2024 Oct 3;26(10). doi: 10.1093/europace/euae252.
6
The Trends in Atrial Fibrillation-Related Mortality before, during, and after the COVID-19 Pandemic Peak in the United States.
J Clin Med. 2024 Aug 15;13(16):4813. doi: 10.3390/jcm13164813.
7
Permanent and Persistent Atrial Fibrillations Are Independent Risk Factors of Mortality after Severe COVID-19.
J Clin Med. 2024 May 26;13(11):3112. doi: 10.3390/jcm13113112.
8
Incidence and prognostic significance of newly-diagnosed atrial fibrillation among older U.S. veterans hospitalized with COVID-19.
Sci Rep. 2024 Jan 10;14(1):952. doi: 10.1038/s41598-024-51177-6.
9
Long-Term Mortality after New-Onset Atrial Fibrillation in COVID-19.
J Clin Med. 2023 Apr 18;12(8):2925. doi: 10.3390/jcm12082925.
10
Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment.
Viruses. 2023 Jan 29;15(2):389. doi: 10.3390/v15020389.
本文引用的文献
1
COVID-19 and cardiac arrhythmias.
Heart Rhythm. 2020 Sep;17(9):1439-1444. doi: 10.1016/j.hrthm.2020.06.016. Epub 2020 Jun 22.
2
Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy.
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1796-1800. doi: 10.1093/gerona/glaa146.
3
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.
Eur Heart J. 2020 May 14;41(19):1821-1829. doi: 10.1093/eurheartj/ehaa388.
4
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687. doi: 10.1093/cvr/cvaa106.
Zotero 插件